13.77

4.32% -0.49

Bioventus Inc (BVS)

Overview News Price History Option Chain Financials Discussions Forecast

Bioventus Inc stock is traded at $13.77, with a volume of 549.53K. It is down -4.32% in the last 24 hours and up +13.14% over the past month. Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.

Previous Close:

$14.26

Open:

$14.53

24h Volume:

549.53K

Relative Volume:

0.74

Market Cap:

$1.16B

Revenue:

$568.09M

Net Income/Loss:

$27.27M

P/E Ratio:

42.03

EPS:

0.3276

Net Cash Flow:

$71.41M

1W Performance:

-2.26%

1M Performance:

+13.14%

6M Performance:

+62.82%

1Y Performance:

+85.13%

1-Day Range:

$13.64

$14.53

1-Week Range:

$13.48

$14.53

52-Week Range:

$6.255

$15.89

Bioventus Inc Stock (BVS) Company Profile

Name

Bioventus Inc

Sector

Healthcare (1089)

Industry

Medical Devices (141)

Phone

(919) 474-6700

Address

4721 EMPEROR BOULEVARD, SUITE 100, DURHAM

Employee

940

Twitter

Next Earnings Date

2026-08-05

Latest SEC Filings

BVS's Discussions on Twitter

Compare BVS vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BVS Bioventus Inc	13.77	1.20B	568.09M	27.27M	71.41M	0.3276
ABT Abbott Laboratories	110.23	192.51B	46.59B	5.41B	7.38B	3.0938
SYK Stryker Corp	332.55	130.11B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	90.62	116.83B	36.36B	4.84B	5.43B	3.7261
BSX Boston Scientific Corp	51.56	75.11B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	90.86	52.80B	6.30B	1.07B	1.09B	1.8406

Bioventus Inc Stock (BVS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-27-26	Initiated	CJS Securities	Market Outperform
Feb-09-26	Initiated	Barrington Research	Outperform
Jul-07-25	Initiated	Cantor Fitzgerald	Overweight
Dec-17-24	Upgrade	JP Morgan	Underweight → Neutral
Dec-07-23	Upgrade	Canaccord Genuity	Hold → Buy
Aug-09-23	Upgrade	Craig Hallum	Hold → Buy
Nov-22-22	Downgrade	Craig Hallum	Buy → Hold
Nov-09-22	Downgrade	Canaccord Genuity	Buy → Hold
Nov-09-22	Downgrade	JP Morgan	Overweight → Underweight
Mar-15-22	Initiated	Craig Hallum	Buy
Nov-15-21	Resumed	Morgan Stanley	Overweight
Nov-10-21	Resumed	JP Morgan	Overweight
Jul-01-21	Downgrade	Goldman	Buy → Neutral
Mar-08-21	Initiated	Canaccord Genuity	Buy
Mar-08-21	Initiated	Goldman	Buy
Mar-08-21	Initiated	JP Morgan	Overweight
Mar-08-21	Initiated	Morgan Stanley	Overweight

View All

Bioventus Inc Stock (BVS) Latest News

10:03 AM

Bioventus (NASDAQ:BVS) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says - marketbeat.com

08:37 AM

08:10 AM

Bioventus' (BVS) "Overweight" Rating Reiterated at Cantor Fitzgerald - marketbeat.com

08:10 AM

Aug 14, 2026

(BVS) and the Role of Price-Sensitive Allocations - Stock Traders Daily

Aug 14, 2026

Aug 13, 2026

Bioventus (BVS) Q2 2026 Earnings Call Transcript - The Globe and Mail

Aug 13, 2026

Aug 11, 2026

Dimensional Fund Advisors LP Increases Position in Bioventus Inc. $BVS - marketbeat.com

Aug 11, 2026

Aug 10, 2026

Bioventus (BVS) Stock Still Looks Like A Bargain On Earnings - Yahoo Finance

Aug 10, 2026

The Bull Case For Bioventus (BVS) Could Change Following Its Q2 Earnings Surge And Reaffirmed 2026 Guidance - Yahoo Finance

Aug 10, 2026

Aug 09, 2026

Bioventus (NASDAQ:BVS) Gains Attention After Strong Quarterly Update - Kalkine Media

Aug 09, 2026

Sei Investments Co. Boosts Holdings in Bioventus Inc. $BVS - marketbeat.com

Aug 09, 2026

Bioventus Inc. (NASDAQ:BVS) Receives Consensus Recommendation of "Buy" from Brokerages - MarketBeat

Aug 09, 2026

Aug 08, 2026

Bioventus (BVS) Is Up 6.1% After Reaffirming 2026 Sales Outlook And Strong Q2 Earnings Jump - Sahm

Aug 08, 2026